Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

Ann Intern Med. 2005 Sep 6;143(5):355-61. doi: 10.7326/0003-4819-143-5-200509060-00011.

Abstract

This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, along with the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is included in the evidence synthesis available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The recommendation is also posted on the Web site of the National Guideline Clearinghouse (http://www.guideline.gov).

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / prevention & control
  • Evidence-Based Medicine
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Counseling
  • Genetic Predisposition to Disease*
  • Humans
  • Medical History Taking
  • Mutation*
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / prevention & control
  • Risk Assessment